High-dose adenosine for refractory supraventricular tachycardia: a case report and literature review

Gal Dadi1, Daniel Fink2, Giora Weiser3

  • 11Pediatric Department,Shaare Zedek Medical Center,Jerusalem,Israel.

Cardiology in the Young
|December 20, 2016
PubMed

Insights

Supraventricular tachycardia in infants can be serious. A higher dose of adenosine successfully treated an infant whose condition was resistant to standard treatments, including electrical cardioversion.

Area of Science:

  • Pediatric Cardiology
  • Electrophysiology
  • Critical Care Medicine

Background:

  • Supraventricular tachycardia (SVT) is a common significant arrhythmia in children.
  • Prolonged SVT can lead to heart failure and cardiogenic shock, necessitating prompt intervention.
  • Standard treatments include vagal maneuvers, intravenous adenosine, and electrical cardioversion for unstable patients.

Observation:

  • An infant presented with unstable supraventricular tachycardia.
  • The infant's condition was refractory to electrical cardioversion.
  • Recommended doses of intravenous adenosine were also ineffective.

Findings:

  • A higher-than-standard dose of adenosine was administered to the infant.
  • The infant reverted to sinus rhythm following the administration of the higher adenosine dose.
  • This suggests potential efficacy of increased adenosine dosage in refractory pediatric SVT.

Implications:

  • Higher doses of adenosine may be a viable treatment option for refractory supraventricular tachycardia in infants.
  • This finding could alter current treatment protocols for pediatric cardiac emergencies.
  • Further research is warranted to establish safety and efficacy of higher-dose adenosine in pediatric refractory SVT.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
553
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
753
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.2K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.4K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.7K